glp-1 agonists pills for weight loss America's Poison Centers Understanding new weight-loss drugs -
Description
Complement and microglia mediate early synapse loss in Alzheimer mouse models
It seems cheaper and safer in the long run.
The drugs were developed and initially approved to treat type 2 diabetes, but stronger doses were found to help people effectively lose weight
Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
doi:10.1038/s41366-025-01859-6 51
These studies will help determine optimal dosing, identify which patient populations benefit most, and establish the long-term safety profile for this dual-purpose application
